Faricimab in neovascular AMD: first report of real-world outcomes in an independent retina clinic

被引：0
|
作者：
Paulo Eduardo Stanga
Francisco Javier Valentín-Bravo
Sebastian Eduardo Francis Stanga
Ursula Inge Reinstein
Salvador Pastor-Idoate
Susan M. Downes
机构：
[1] The Retina Clinic London,
[2] UCL Institute of Ophthalmology,undefined
来源：
Eye | 2023年 / 37卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3282 / 3289
页数：7
相关论文
共 50 条
  • [1] Faricimab in neovascular AMD: first report of real-world outcomes in an independent retina clinic
    Stanga, Paulo Eduardo
    Valentin-Bravo, Francisco Javier
    Stanga, Sebastian Eduardo Francis
    Reinstein, Ursula Inge
    Pastor-Idoate, Salvador
    Downes, Susan M.
    [J]. EYE, 2023, 37 (15) : 3282 - 3289
  • [2] Trends in Real-World Neovascular AMD Treatment Outcomes in the UK
    Mehta, Hemal
    Kim, Leah N.
    Mathis, Thibaud
    Zalmay, Pardis
    Ghanchi, Faruque
    Amoaku, Winfried M.
    Kodjikian, Laurent
    [J]. CLINICAL OPHTHALMOLOGY, 2020, 14 : 3331 - 3342
  • [3] Real-world analysis of brolucizumab in neovascular AMD
    Rave, Vanessa
    Sharma, Kayshaliya
    Wagner, Alan
    Kapoor, Kapil
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [4] Real-World Outcomes of a Loading Phase with Intravitreal Faricimab in Neovascular Age-Related Macular Degeneration (n-AMD) and Diabetic Macular Edema (DME)
    Giancipoli, Ermete
    Guglielmi, Antonella
    Bux, Anna Valeria
    Clima, Giulia Maria Emilia
    Pignatelli, Francesco
    Boscia, Francesco
    Viggiano, Pasquale
    Boscia, Giacomo
    Fortunato, Francesca
    Besozzi, Gianluca
    Niro, Alfredo
    Dore, Stefano
    Iaculli, Cristiana
    [J]. OPHTHALMOLOGY AND THERAPY, 2024, : 2163 - 2184
  • [5] Real-World Outcomes of Faricimab Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
    Quah, Nicole Q. X.
    Javed, Khawaja Muhammad Ammar Ali
    Arbi, Lamees
    Hanumunthadu, Daren
    [J]. CLINICAL OPHTHALMOLOGY, 2024, 18 : 1479 - 1490
  • [6] Early real-world outcomes in patients with neovascular Age-related Macular Degeneration (nAMD) treated with Faricimab
    Raslan, Walid
    Younis, Saad
    Fabozzi, Lorenzo
    Hassan, Islam
    Palmieri, Filomena
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [7] Cost Efficacy and Challenges of Real-world Brolucizumab use for Neovascular AMD
    Sharma, Kayshaliya
    Rave, Vanessa
    Wagner, Alan
    Kapoor, Kapil
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [8] Short-term real-world outcomes following intravitreal brolucizumab for neovascular AMD: SHIFT study
    Bulirsch, Louisa Maria
    Sassmannshausen, Marlene
    Nadal, Jennifer
    Liegl, Raffael
    Thiele, Sarah
    Holz, Frank G.
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2022, 106 (09) : 1288 - 1294
  • [9] Real World Vienna: The VIBES Study - Outcomes and procedures in neovascular AMD
    Gerendas, Bianca S.
    Sadeghipour, Amir
    Buehl, Wolf
    Sacu, Stefan
    Schmidt-Erfurth, Ursula
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [10] The UK Neovascular AMD Database Report 3: inter-centre variation in visual acuity outcomes and establishing real-world measures of care
    Liew, G.
    Lee, A. Y.
    Zarranz-Ventura, J.
    Stratton, I.
    Bunce, C.
    Chakravarthy, U.
    Lee, C. S.
    Keane, P. A.
    Sim, D. A.
    Akerele, T.
    McKibbin, M.
    Downey, L.
    Natha, S.
    Bailey, C.
    Khan, R.
    Antcliff, R.
    Armstrong, S.
    Varma, A.
    Kumar, V.
    Tsaloumas, M.
    Mandal, K.
    Egan, C.
    Johnston, R. L.
    Tufail, A.
    [J]. EYE, 2016, 30 (11) : 1462 - 1468
12345